Compare Stocks

Date Range: 

 BiondVax PharmaceuticalsEntera BioPharmaCyte BiotechAcorda TherapeuticsSeneca Biopharma
SymbolNASDAQ:BVXVNASDAQ:ENTXOTCMKTS:PMCBNASDAQ:ACORNASDAQ:SNCA
Price Information
Current Price$2.86$3.18$0.02$4.60$5.97
52 Week RangeN/ABuyN/AHoldN/A
MarketRank™
Overall Score0.51.20.51.40.5
Analysis Score0.03.50.03.00.0
Community Score2.52.52.42.22.3
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.01.90.0
Analyst Ratings
Consensus RecommendationN/ABuyN/AHoldN/A
Consensus Price TargetN/A$11.00N/A$20.50N/A
% Upside from Price TargetN/A245.91% upsideN/A345.65% upsideN/A
Trade Information
Market Cap$32.47 million$36.35 million$36.14 million$43.65 million$103.26 million
Beta2.411.410.490.751.83
Average Volume785,4446,299,81014,217,084782,3103,775,260
Sales & Book Value
Annual RevenueN/A$240,000.00N/A$192.41 million$10,000.00
Price / SalesN/A151.45N/A0.2310,325.71
CashflowN/AN/AN/A$20.00 per shareN/A
Price / CashN/AN/AN/A0.23N/A
Book Value($2.88) per share$1.04 per shareN/A$38.82 per share$1.33 per share
Price / BookN/A3.06N/A0.124.49
Profitability
Net Income$-31,600,000.00$-10,800,000.00$-3,830,000.00$-272,970,000.00$-8,350,000.00
EPS($3.60)N/AN/A($11.94)N/A
Trailing P/E RatioN/AN/A0.000.830.00
Forward P/E Ratio∞∞∞N/A∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-2,173.54%N/A29.71%-230.34%
Return on Equity (ROE)N/A-128.04%-57.82%-8.60%-122.20%
Return on Assets (ROA)-135.18%-85.73%-49.63%-3.51%-110.61%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.52%N/A
Current Ratio6.48%2.67%5.92%1.09%14.96%
Quick Ratio6.48%2.67%5.92%0.88%14.96%
Ownership Information
Institutional Ownership Percentage4.04%N/A0.02%N/A5.24%
Insider Ownership Percentage6.03%N/AN/A6.80%2.11%
Miscellaneous
Employees251641677
Shares Outstanding11.35 million11.43 million2.39 billion9.49 million17.30 million
Next Earnings Date6/29/2021 (Estimated)5/20/2021 (Estimated)8/12/2021 (Estimated)8/3/2021 (Estimated)5/21/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Seneca Biopharma, Inc. (NASDAQ:SNCA) Sees Large Increase in Short InterestSeneca Biopharma, Inc. (NASDAQ:SNCA) Sees Large Increase in Short Interest
americanbankingnews.com - May 4 at 2:26 PM
Seneca Biopharma Inc. [SNCA] Revenue clocked in at $0.01 million, up 90.91% YTD: What’s Next?Seneca Biopharma Inc. [SNCA] Revenue clocked in at $0.01 million, up 90.91% YTD: What’s Next?
dbtnews.com - April 28 at 12:57 AM
Why Seneca Biopharma Stock is Trading Higher TodayWhy Seneca Biopharma Stock is Trading Higher Today
msn.com - April 26 at 11:07 PM
Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.
finance.yahoo.com - April 26 at 8:04 AM
Market cap of Seneca Biopharma Inc. [SNCA] reaches 27.43M – now what?Market cap of Seneca Biopharma Inc. [SNCA] reaches 27.43M – now what?
dbtnews.com - April 20 at 1:02 PM
Leading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions in Open Label StudyLeading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions in Open Label Study
finance.yahoo.com - April 20 at 7:49 AM
Leading BioSciences Provides Update to Seneca Biopharma, Inc. Stockholders on Merger Closing Process Following Virtual Special Meeting on April 23, 2021 and Upcoming Milestones Following Planned Close of MergerLeading BioSciences Provides Update to Seneca Biopharma, Inc. Stockholders on Merger Closing Process Following Virtual Special Meeting on April 23, 2021 and Upcoming Milestones Following Planned Close of Merger
finance.yahoo.com - April 19 at 9:58 AM
Seneca Biopharma, Inc. (NASDAQ:SNCA) Short Interest UpdateSeneca Biopharma, Inc. (NASDAQ:SNCA) Short Interest Update
americanbankingnews.com - April 14 at 8:26 AM
Leading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to ...Leading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to ...
apnews.com - April 13 at 10:22 AM
Leading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to Vote at the Virtual Special Meeting on April 23, 2021Leading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to Vote at the Virtual Special Meeting on April 23, 2021
benzinga.com - April 13 at 12:31 AM
Seneca Biopharma, Inc. Announces (i) Voting Results from the Special Meeting of Stockholders and (ii) New Special Meeting Date of April 23, 2021Seneca Biopharma, Inc. Announces (i) Voting Results from the Special Meeting of Stockholders and (ii) New Special Meeting Date of April 23, 2021
finance.yahoo.com - April 12 at 8:08 AM
SNCA Stock: Merger Hopes Excite InvestorsSNCA Stock: Merger Hopes Excite Investors
cnafinance.com - April 5 at 10:55 AM
Leading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of ...Leading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of ...
apnews.com - April 2 at 12:55 PM
Leading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of Proposed Merger with Seneca Biopharma, Inc.Leading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of Proposed Merger with Seneca Biopharma, Inc.
benzinga.com - April 2 at 12:12 PM
Leading BioSciences Encourages Seneca Biopharma Stockholders to Vote “FOR” Proposed MergerLeading BioSciences Encourages Seneca Biopharma Stockholders to Vote “FOR” Proposed Merger
finance.yahoo.com - March 31 at 6:49 PM
Seneca Stockholder LetterSeneca Stockholder Letter
finance.yahoo.com - March 30 at 7:41 AM
Where do analysts think the Seneca Biopharma, Inc. (NASDAQ:SNCA) is goingWhere do analysts think the Seneca Biopharma, Inc. (NASDAQ:SNCA) is going
stocksregister.com - March 29 at 9:46 AM
Seneca Special Meeting Q&ASeneca Special Meeting Q&A
finance.yahoo.com - March 26 at 8:47 PM
12-month price target for Seneca Biopharma, Inc. (NASDAQ:SNCA) now sits at $52012-month price target for Seneca Biopharma, Inc. (NASDAQ:SNCA) now sits at $520
marketingsentinel.com - March 26 at 10:40 AM
Seneca Announces New Special Meeting Date of April 9, 2021Seneca Announces New Special Meeting Date of April 9, 2021
finance.yahoo.com - March 24 at 6:45 PM
Seneca Biopharma Reports 2020 Yearend ResultsSeneca Biopharma Reports 2020 Yearend Results
finance.yahoo.com - March 22 at 8:39 PM
Why Seneca Biopharmas Stock is Trading Higher TodayWhy Seneca Biopharma's Stock is Trading Higher Today
benzinga.com - March 22 at 3:38 PM
SNCA Stock Price Increases Over 80% Pre-Market: Why It HappenedSNCA Stock Price Increases Over 80% Pre-Market: Why It Happened
pulse2.com - March 22 at 10:38 AM
SNCA Stock: Here’s Why Seneca Biopharma Is ClimbingSNCA Stock: Here’s Why Seneca Biopharma Is Climbing
cnafinance.com - March 22 at 10:38 AM
SNCA Stock Price Increases Over 30% Pre-Market: Why It HappenedSNCA Stock Price Increases Over 30% Pre-Market: Why It Happened
pulse2.com - March 18 at 12:34 PM
DateCompanyBrokerageAction
3/29/2021Entera BioAegisInitiated Coverage
3/11/2021Entera BioMaxim GroupBoost Price Target
1/13/2021Acorda TherapeuticsCowenBoost Price Target
8/11/2020Acorda TherapeuticsJefferies Financial GroupReiterated Rating
5/6/2020Acorda TherapeuticsHC WainwrightReiterated Rating
2/16/2020Acorda TherapeuticsJPMorgan Chase & Co.Reiterated Rating
8/2/2019Acorda TherapeuticsStifel NicolausLower Price Target
8/2/2019Acorda TherapeuticsWedbushLower Price Target
8/2/2019Acorda TherapeuticsCantor FitzgeraldLower Price Target
3/19/2019Acorda TherapeuticsOppenheimerReiterated Rating
(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.